149 related articles for article (PubMed ID: 2677951)
1. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
Anthony BF; Concepcion NF
Pediatr Res; 1989 Oct; 26(4):383-7. PubMed ID: 2677951
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.
Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF
Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825
[TBL] [Abstract][Full Text] [Related]
4. Functional activity of class-specific antibodies to type III, group B streptococcus.
Campbell JR; Baker CJ; Metzger TG; Edwards MS
Pediatr Res; 1988 Jan; 23(1):31-4. PubMed ID: 3277150
[TBL] [Abstract][Full Text] [Related]
5. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement.
Anderson DC; Hughes BJ; Edwards MS; Buffone GJ; Baker CJ
Pediatr Res; 1983 Jun; 17(6):496-502. PubMed ID: 6348689
[TBL] [Abstract][Full Text] [Related]
6. Variations in the opsonic requirements of group B streptococcus type III.
Hastings MJ; Easmon CS
Br J Exp Pathol; 1981 Oct; 62(5):519-25. PubMed ID: 7028075
[TBL] [Abstract][Full Text] [Related]
7. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
Garbett ND; Munro CS; Cole PJ
Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
[TBL] [Abstract][Full Text] [Related]
8. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
Butko P; Nicholson-Weller A; Wessels MR
J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
[TBL] [Abstract][Full Text] [Related]
9. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
Hemming VG; Hall RT; Rhodes PG; Shigeoka AO; Hill HR
J Clin Invest; 1976 Dec; 58(6):1379-87. PubMed ID: 62761
[TBL] [Abstract][Full Text] [Related]
10. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
Givner LB
Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
[TBL] [Abstract][Full Text] [Related]
11. Serum opsonic activity in rodent malaria: functional and immunochemical characteristics in vitro.
Hunter KW; Winkelstein JA; Simpson TW
J Immunol; 1979 Dec; 123(6):2582-7. PubMed ID: 387873
[TBL] [Abstract][Full Text] [Related]
12. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
[TBL] [Abstract][Full Text] [Related]
13. A human IgG 3 is opsonic in vitro against type III group B streptococci.
Kim JS; Kim KS; Wass CA; Short JA; Heiner DC
J Clin Immunol; 1990 May; 10(3):154-9. PubMed ID: 2195055
[TBL] [Abstract][Full Text] [Related]
14. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR
J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414
[TBL] [Abstract][Full Text] [Related]
15. Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region.
Fischetti VA
J Immunol; 1983 Feb; 130(2):896-902. PubMed ID: 6336773
[TBL] [Abstract][Full Text] [Related]
16. Opsonic activity of immunoglobulin prepared for intravenous use.
Hetherington SV; Giebink GS
J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
[TBL] [Abstract][Full Text] [Related]
17. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
Givner LB; Edwards MS; Baker CJ
J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
[TBL] [Abstract][Full Text] [Related]
18. Development of IgM antibody to group B Streptococcus type III in human infants.
Boyer KM; Klegerman ME; Gotoff SP
J Infect Dis; 1992 Jun; 165(6):1049-55. PubMed ID: 1583322
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
Fischer GW
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
[TBL] [Abstract][Full Text] [Related]
20. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
Shigeoka AO; Jensen CL; Pincus SH; Hill HR
J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
